Objective To probe the effection of estrogen on uterine fibrosis following transcervical resection of septum (TCRS). Methods Totally 110 patients who underwent hysteroscopic septum resection in our hospital from January 2016 to May 2017 were allocated into two groups. In experimental group (58 patients), women received postoperative estrogen therapy, No medication was received in control group (52 patients). Further hysteroscopy was performed to assess the uterine cavity in one month later of the initial surgery. Endometrium was collected to detect the expressions of TGF-β and CTGF through immunohistochemistry and PCR. Results The postoperative adhesion rates between the two groups at one month were 1.9% (control group) and 5.1% (experimental group), respectively (P > 0.05). The expression levels of TGF-β and CTGF through immunohistochemistry and PCR in endometrium were no significant difference between the two groups (P > 0.05). Conclusions Estrogen cannot change the process of uterine fibrosis following TCRS, which is related to that estrogen cannot change the expressions of TGF-β and CTGF.